×
Hero Background

Rabies Treatment Companies

ID: MRFR/Pharma/1098-HCR
200 Pages
Rahul Gotadki
October 2025

Rabies treatment primarily involves post-exposure prophylaxis (PEP), which includes a series of rabies vaccinations and, in some cases, rabies immune globulin (RIG) administration. There are several pharmaceutical companies and organizations involved in the production and distribution of rabies vaccines and related treatments. It's important to note that as of my last knowledge update in January 2022, the landscape of these companies may have changed, and new developments may have occurred. 

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Rabies Treatment Market Research Report- Forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Rabies Treatment Market

Rabies Treatment Key Companies

Latest Rabies Treatment Companies Update



Sanofi Pasteur's rabies monoclonal antibody program: In October 2023, Sanofi Pasteur announced the initiation of Phase 1 clinical trials for its novel rabies monoclonal antibody program. This potentially game-changing development aims to offer a long-acting, non-vaccine alternative for post-exposure prophylaxis (PEP).


New rabies immunoglobulin (RIG) formulations: Bavarian Nordic received EU approval for its Rabipur® P intramuscular/subcutaneous rabies immunoglobulin formulation in August 2023. This offers healthcare professionals new options for administering RIG, potentially improving accessibility and convenience.


List of Rabies Treatment Key Companies in the Market



  • Sanofi (France)

  • Merck & Co. Inc.

  • CSC Pharmaceuticals International

  • Pfizer (U.S.)

  • VBI Vaccines Inc. (U.S.)

  • Taj Pharmaceuticals Limited (India)

  • Bio Med Pvt. Ltd.

  • Bavarian Nordic(U.S.)

  • Solvay(U.S.)

  • Informa plc.(U.S.)